Article
Implementation of genotype-guided dosing of warfarin with point-of-care genetic testing in three UK clinics: a matched cohort study.
BMC medicine - 8 Apr 2019
Jorgensen Andrea L, Prince Clare, Fitzgerald Gail, Hanson Anita, Downing Jennifer, Reynolds Julia, Zhang J Eunice, Alfirevic Ana, Pirmohamed Munir
Abstract excerpt
BACKGROUND: Warfarin is a widely used oral anticoagulant. Determining the correct dose required to maintain the international normalised ratio (INR) within a therapeutic range can be challenging. In a previous trial, we showed that a dosing algorithm incorporating point-of-care genotyping information ('POCT-GGD' approach) led to improved anticoagulation control. To determine whether this approach could translate...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
